(Q36220831)

English

Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus (English)

1 reference

Europe PubMed Central

12 August 2017

hydroxychloroquine

0 references

1 reference

based on heuristic

inferred from title

Nathalie Costedoat-Chalumeau

2

object named as

Nathalie Costedoat-Chalumeau

1 reference

Europe PubMed Central

12 August 2017

Jean-Charles Piette

9

object named as

Jean-Charles Piette

1 reference

Europe PubMed Central

12 August 2017

Munther A. Khamashta

4

object named as

Munther A Khamashta

1 reference

Europe PubMed Central

12 August 2017

1

object named as

Peter M Izmirly

2 references

ORCID Public Data File 2021

Europe PubMed Central

12 August 2017

10

object named as

Jill P Buyon

1 reference

Europe PubMed Central

12 August 2017

3

object named as

Cecilia N Pisoni

1 reference

Europe PubMed Central

12 August 2017

author name string

Mimi Y Kim

5

1 reference

Europe PubMed Central

12 August 2017

Amit Saxena

6

1 reference

Europe PubMed Central

12 August 2017

Deborah Friedman

7

1 reference

Europe PubMed Central

12 August 2017

Carolina Llanos

8

1 reference

Europe PubMed Central

12 August 2017

language of work or name

0 references

publication date

24 May 2012

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

126

1 reference

Europe PubMed Central

12 August 2017

1

1 reference

Europe PubMed Central

12 August 2017

76-82

1 reference

Europe PubMed Central

12 August 2017

Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

A novel role of endothelin-1 in linking Toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Glucocorticoids in pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Hydroxychloroquine in lupus pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Disease-modifying antirheumatic drugs in pregnancy: current status and implications for the future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Variable selection for propensity score models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

1 October 2017

Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

29 June 2018

Matching using estimated propensity scores: relating theory to practice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

29 June 2018

Retinal degeneration in 2 children following preventive antimalarial treatment of the mother during pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

29 June 2018

Ototoxicity of Chloroquine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

29 June 2018

Optimal two-stage designs for phase II clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

29 June 2018

Ineffective therapy, underpowered studies, or merely too little, too late? Risk factors and impact of maternal corticosteroid treatment on outcome in antibody-associated fetal heart block

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

22 September 2018

Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

22 September 2018

Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

22 September 2018

Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

22 September 2018

Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437628

5 December 2018

The rate of recurrence of isolated congenital heart block: a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22626746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women

1 reference

https://pubmed.ncbi.nlm.nih.gov/22626746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22626746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22626746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22626746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neonatal lupus erythematosus: results of maternal corticosteroid therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22626746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimalarial agents: closing the gate on Toll-like receptors?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22626746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses

1 reference

https://pubmed.ncbi.nlm.nih.gov/22626746

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1161/CIRCULATIONAHA.111.089268

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36220831&oldid=1989780439"